INDEMNITY AGREEMENTIndemnity Agreement • November 1st, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • Delaware
THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of , 2017 is made and entered into by and between NEUROCRINE BIOSCIENCES, INC., a Delaware corporation (the “Company”), and (“Indemnitee”).
AMENDED AND RESTATED PRODUCT AGREEMENT (INGREZZATM (valbenazine))Product Agreement • November 1st, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances)
This Amended and Restated Product Agreement (this “Product Agreement”) is issued under the Master Manufacturing Services Agreement dated 28 November 2016 between Patheon UK Limited and Neurocrine Biosciences Inc. (the “Master Agreement”), and is entered into 27 June 2017 (the “Effective Date”), between Patheon UK Limited, a corporation existing under the laws of England, having a principal place of business at Kingfisher Drive, Covingham, Swindon, SN3 5BZ, England (“Patheon”) and Neurocrine Biosciences Inc, 12780 El Camino Real, San Diego 92130, California, USA (“Client”).
SECOND AMENDMENT TO AMENDED AND RESTATED LEASELease • November 1st, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances)
This SECOND AMENDMENT TO AMENDED AND RESTATED LEASE (“Second Amendment”) is made and entered into as of October 12, 2017, by and between KILROY REALTY, L.P., a Delaware limited partnership (“Landlord”), and NEUROCRINE BIOSCIENCES, INC., a Delaware corporation (“Tenant”).
